
Henry Schein (HSIC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
3.2B
Gross Profit
1.0B
31.57%
Operating Income
200.0M
6.31%
Net Income
113.0M
3.57%
EPS (Diluted)
$0.88
Balance Sheet Metrics
Total Assets
10.5B
Total Liabilities
5.8B
Shareholders Equity
4.7B
Debt to Equity
1.22
Cash Flow Metrics
Operating Cash Flow
147.0M
Free Cash Flow
-6.0M
Revenue & Profitability Trend
Henry Schein Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 12.7B | 12.3B | 12.6B | 12.4B | 10.1B |
Cost of Goods Sold | 8.7B | 8.5B | 8.8B | 8.7B | 7.3B |
Gross Profit | 4.0B | 3.9B | 3.8B | 3.7B | 2.8B |
Gross Margin % | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 3.0B | 3.0B | 2.8B | 2.6B | 2.2B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 3.0B | 3.0B | 2.8B | 2.6B | 2.2B |
Operating Income | 731.0M | 695.0M | 878.0M | 860.0M | 567.4M |
Operating Margin % | 5.8% | 5.6% | 6.9% | 6.9% | 5.6% |
Non-Operating Items | |||||
Interest Income | 24.0M | 17.0M | 8.0M | 6.0M | 9.8M |
Interest Expense | 131.0M | 87.0M | 35.0M | 27.0M | 41.4M |
Other Non-Operating Income | -111.0M | -83.0M | -130.0M | -8.0M | -36.0M |
Pre-tax Income | 513.0M | 542.0M | 721.0M | 831.0M | 499.9M |
Income Tax | 128.0M | 120.0M | 170.0M | 198.0M | 95.4M |
Effective Tax Rate % | 25.0% | 22.1% | 23.6% | 23.8% | 19.1% |
Net Income | 398.0M | 436.0M | 566.0M | 660.0M | 419.4M |
Net Margin % | 3.1% | 3.5% | 4.5% | 5.3% | 4.1% |
Key Metrics | |||||
EBITDA | 1.0B | 957.0M | 1.1B | 1.1B | 758.9M |
EPS (Basic) | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 |
EPS (Diluted) | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 |
Basic Shares Outstanding | 126788997 | 130618990 | 136064221 | 140091000 | 142504000 |
Diluted Shares Outstanding | 126788997 | 130618990 | 136064221 | 140091000 | 142504000 |
Income Statement Trend
Henry Schein Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 122.0M | 171.0M | 117.0M | 118.0M | 421.2M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 1.5B | 1.9B | 1.4B | 1.5B | 1.4B |
Inventory | 1.8B | 1.8B | 2.0B | 1.9B | 1.5B |
Other Current Assets | 569.0M | 639.0M | 466.0M | 413.0M | - |
Total Current Assets | 4.0B | 4.5B | 4.0B | 3.8B | 3.8B |
Non-Current Assets | |||||
Property, Plant & Equipment | 293.0M | 325.0M | 284.0M | 325.0M | 288.8M |
Goodwill | 8.8B | 8.7B | 6.4B | 6.4B | 5.5B |
Intangible Assets | 1.0B | 916.0M | 587.0M | 668.0M | 479.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 255.0M | 234.0M | 272.0M | 218.0M | 160.6M |
Total Non-Current Assets | 6.2B | 6.1B | 4.6B | 4.6B | 4.0B |
Total Assets | 10.2B | 10.6B | 8.6B | 8.5B | 7.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 962.0M | 1.0B | 1.0B | 1.1B | 1.0B |
Short-term Debt | 781.0M | 494.0M | 182.0M | 138.0M | 247.9M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 2.8B | 2.7B | 2.2B | 2.3B | 2.3B |
Non-Current Liabilities | |||||
Long-term Debt | 2.1B | 2.2B | 1.3B | 1.1B | 754.5M |
Deferred Tax Liabilities | 102.0M | 54.0M | 36.0M | 42.0M | 30.1M |
Other Non-Current Liabilities | 387.0M | 436.0M | 361.0M | 377.0M | 392.8M |
Total Non-Current Liabilities | 2.6B | 2.7B | 1.7B | 1.5B | 1.2B |
Total Liabilities | 5.4B | 5.4B | 3.9B | 3.8B | 3.5B |
Equity | |||||
Common Stock | 1.0M | 1.0M | 1.0M | 1.0M | 1.4M |
Retained Earnings | 3.8B | 3.9B | 3.7B | 3.6B | 3.5B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 4.8B | 5.2B | 4.7B | 4.7B | 4.3B |
Key Metrics | |||||
Total Debt | 2.9B | 2.7B | 1.5B | 1.2B | 1.0B |
Working Capital | 1.2B | 1.8B | 1.8B | 1.5B | 1.5B |
Balance Sheet Composition
Henry Schein Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 398.0M | 436.0M | 566.0M | 660.0M | 418.4M |
Depreciation & Amortization | 268.0M | 248.0M | 212.0M | 210.0M | 185.5M |
Stock-Based Compensation | 39.0M | 39.0M | 54.0M | 78.0M | 8.8M |
Working Capital Changes | 303.0M | -234.0M | -185.0M | -282.0M | -227.6M |
Operating Cash Flow | 957.0M | 503.0M | 659.0M | 643.0M | 312.3M |
Investing Activities | |||||
Capital Expenditures | -148.0M | -147.0M | -96.0M | -79.0M | -48.8M |
Acquisitions | -230.0M | -955.0M | -158.0M | -561.0M | -46.2M |
Investment Purchases | - | - | - | - | -60.2M |
Investment Sales | 0 | 22.0M | 0 | 0 | 14.0M |
Investing Cash Flow | -391.0M | -1.1B | -244.0M | -644.0M | -161.2M |
Financing Activities | |||||
Share Repurchases | -385.0M | -250.0M | -485.0M | -401.0M | -73.8M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 120.0M | 1.4B | 270.0M | 305.0M | 546.5M |
Debt Repayment | -318.0M | -468.0M | -59.0M | -122.0M | -611.2M |
Financing Cash Flow | -516.0M | 700.0M | -317.0M | -333.0M | -136.7M |
Free Cash Flow | 661.0M | 313.0M | 474.0M | 598.0M | 550.1M |
Net Change in Cash | 50.0M | 108.0M | 98.0M | -334.0M | 14.4M |
Cash Flow Trend
Henry Schein Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.79
Forward P/E
13.03
Price to Book
2.40
Price to Sales
0.64
PEG Ratio
-1.77
Profitability Ratios
Profit Margin
3.05%
Operating Margin
5.40%
Return on Equity
8.12%
Return on Assets
4.54%
Financial Health
Current Ratio
1.41
Debt to Equity
68.55
Beta
0.82
Per Share Data
EPS (TTM)
$3.11
Book Value per Share
$28.26
Revenue per Share
$102.93
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
hsic | 8.2B | 21.79 | 2.40 | 8.12% | 3.05% | 68.55 |
McKesson | 84.2B | 27.10 | -100.73 | -194.51% | 0.84% | -11.52 |
Cencora | 56.7B | 33.80 | 55.93 | 141.78% | 0.55% | 827.73 |
Patterson Companies | 2.8B | 20.48 | 2.80 | 14.11% | 2.13% | 88.87 |
Cardinal Health | 35.7B | 23.20 | -13.52 | -59.26% | 0.70% | -3.56 |
Owens & Minor | 408.6M | -1.11 | -1.44 | -148.42% | -11.18% | -7.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.